Trump’s tariffs bring the nightshade to Botox -Harado Ireland

Peak Crog Patrick dominates the horizon of Westport, a beautiful city on the Atlantic coast of Ireland. On the other hand, dominant economies are not very wonderful gray factory units that produce Botox supplies for the American company. And Donald Trump wants the production of pharmaceuticals to move home.

This week, the US President has strengthened criticism of Irish operations by US companies. Its threats to impose tariffs to encourage investors to refurbish 7,000 westports: about 1500 of them work on Abbvie to make drugs that stand out with wrinkles.

“People have been breathing,” said Geraaldin Horkan, CEO of the Westport’s Wester House, who worked in Allergan absorption abbvie In 2020. “It is like a plane that whirlwinds.”

Ireland became the main base for US pharmaceutical companies, including Pfizer, Eli Lilly and Johnson & Johnson.

In addition to Botox, which leaves the vestport as a powder vial, which can be mixed with a saline before introduction of celebrities or for the treatment of cerebral paralysis or muscle spasms in Ireland, the active drug ingredients, including Viagra, is excluded.

Ireland rushes to the export of pharmaceuticals in the US before any tariff ax falls: in February, 91 percent of all its goods exports to the US were chemicals and related products that include medical and pharmaceuticals. According to official data on trade data, Irish pharmaceuticals in the US reached almost 20 billion euros in the first two months, compared to EUR 44 billion for the last year.

Despite the introduction of Trump Global Tariffs, which he focused last week with a base world rate in 10 percent before the trade transactions with the EU and other countries, pharmaceutical goods currently have no tariffs.

Foreign and Trade Minister Ireland Simon Harris says it will be “out of place” and “bizarre” to impose tariffs during the negotiations.

But the appeal looks increasingly unlikely. The US Department of Trade has launched an investigation into “Section 232” in a sector that will restrict imports to the president to be a threat to national security.

This can potentially lead to tariffs in “next month -second month,” said US trade secretary Howard Lutnit.

Trump, who used a meeting with Taoiseach Micheál Martin last month to complain that on Monday Ireland “received the entire US pharmaceutical industry,” again broke out in the sector.

“We no longer create our own drugs, our own pharmaceuticals. Drugs are in Ireland, and they are in many other places – China,” he said.

In 1977, Allergan opened a plant for contact lenses and EYECARE products to Westport. Now the real cash spin-botox, but the object also produces Pharmaceuticals Eyecare, and 70 percent of Westport production is sold in the US, according to the latest recently submitted results of the Irish operation since 2023.

Now Botox has competitors that produce chemically similar products – competitive drugs include Dysport, made by France Ipsen and Xen Merz – but Abbvie says confidently that it can Keep his guidelines.

While Botox for cosmetic purposes are brought 2.72 billion. Dollars in pure income Last year, according to Abbvie, Therapeutic Botox recorded $ 3.3 billion. Tariffs will increase the price for users, and cosmetic applications are not covered by the US health insurance.

Abbvie – which does not officially reveal where it produces its products – invested 160 million euros in the second biological institution in the Westport -2020, and the production cannot be “transferred for the night,” said Peter Flynn, a local advisor and a former international director in Allergan. “(Trump) Cheap remarks do not make any affection,” he said.

“With the help of automation of production lines and constantly increasing quality standards, the focus in Ireland has changed with transnational companies that now use highly skilled and experienced people, many of whom play a key role in the NDCR,” he added.

Ireland – this is the world the third largest pharmaceutical exporter, With 90 sites supplying the EU and other countries as well as the US. Over the last decade, more than 10 billion euros have been invested. Denmark, Switzerland and Singapore are other countries with large pharmaceutical sectors that are now in Trump’s sights.

Many drugs responded by announcing great investments in the US. Johnson & Johnson has promised $ 55 billion over the next four years, Eli Lily has been investing $ 27 billion, and a Swiss drug manufacturer said Novartis that last week would invest $ 23 billion into production and NDDK.

The heads of the pharmaceuticals wrote to the President of the European Commission Ursul von der Leyen, warning that Europe risks losing $ 100 billion in investment and spending the NDDC over the next five years, since US tariffs and proposed EU reforms make the EU less attractive.

But Ireland is uniquely vulnerable to any Trump’s action: besides Big Pharma, it houses the European Staff -Kwater or large operations of the US technological giants having von der Leyen threatened to navigate When the tariff conversations fell.

Tech and Pharma make huge corporation tax contributions that have delivered a huge surplus budget.

Botox also helped Westport grow into a colorful, noisy city on boats, restaurants, hotels, chic shops and traditional bars.

Like the city’s largest employer, the company was a well -known supporter and sponsor of local initiatives and sports teams. “It would be a great loss,” they said, said Adrian Nunan, the owner of the Knockranny House, the first four-star city hotel, located near the plant held by executives and council meetings.

New pharmaceutical factories need a regulatory approval, which may mean years of delay in transferring production to the United States, but analysts have stated that the leaders have already cut the brakes into future investment plans in Ireland.

“We are all extremely concerned,” said Philip Heni, a local pharmacist. “They say that Canada is a 51st state. But with Pharma we are almost.”